NCT02471352 Studies of Dermatologic Diseases Biospecimen Acquisition Protocol
| NCT ID | NCT02471352 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) |
| Condition | Dermatologic Conditions |
| Study Type | OBSERVATIONAL |
| Enrollment | 700 participants |
| Start Date | 2015-06-19 |
| Primary Completion | 2027-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 700 participants in total. It began in 2015-06-19 with a primary completion date of 2027-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Background: \- Skin disease can have many causes. It can have widespread consequences, and in rare cases can lead to death. Researchers want to determine the causes of various types of skin diseases and find a way to treat them. Objectives: \- To determine the causes of various skin diseases and find ways to treat them. Eligibility: * People ages 2 and older who have: * A skin disease or at risk of developing a skin disease OR * A family member of persons with a skin disease * Healthy volunteers ages 2 and older Design: * Participants will be screened under a separate protocol. * Participants may take a survey about how their skin condition affects their quality of life. * Participants will have a medical history and a physical exam including a detailed skin exam. Pictures will be taken of their skin to document any skin disease. * Participants will have specimens collected. This may include: * Several teaspoons of blood taken at each visit * Stool samples * Nail and body fluid (like saliva) samples * Cheek swabs. The inside of the cheek will be scraped for about a minute in each direction to collect cells. * Collection of skin samples with: * A swab (like a Q-tip) * Gently scraping skin to remove the outer layers of cells * Applying and removing 1-inch pieces of tape * Participants may have up to 4 skin biopsies in 12 months, with 4 separate biopsies taken each time. * An area of skin will be numbed with an injection. * A piece of skin the size of a pencil eraser will be removed using a small instrument. * A flat scar usually develops at the biopsy site.
Eligibility Criteria
* INCLUSION CRITERIA: * Eligible participants must: * Have a dermatologic condition, as determined by the PI or AIs, OR --be at risk for developing a dermatologic condition, as determined by the PI or AIs, OR * be a family member of a person with a dermatologic condition OR * be a healthy volunteer, as defined as a person with no known significant health problems. * Be willing to provide biospecimens for research and clinical studies, and for storage to be used for future research. * Subjects of age greater than 0 years old (including only viable neonates) are eligible. EXCLUSION CRITERIA: * Presence of conditions that, in the judgment of the investigator, may put the subject at undue risk or make them unsuitable for participation in the study. * Inability to comply with the requirements of the protocol.
Contact & Investigator
Heidi H Kong, M.D.
PRINCIPAL INVESTIGATOR
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Frequently Asked Questions
Who can join the NCT02471352 clinical trial?
This trial is open to participants of all sexes, aged 1 Day or older, up to 100 Years, studying Dermatologic Conditions. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02471352 currently recruiting?
Yes, NCT02471352 is actively recruiting participants. Contact the research team at NIAMSderm@nih.gov for enrollment information.
Where is the NCT02471352 trial being conducted?
This trial is being conducted at Bethesda, United States.
Who is sponsoring the NCT02471352 clinical trial?
NCT02471352 is sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). The principal investigator is Heidi H Kong, M.D. at National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). The trial plans to enroll 700 participants.